FIELD: organic chemistry, medicine, pharmacology, biochemistry.
SUBSTANCE: invention relates a pharmaceutical composition, pharmaceutical combination and a set for treatment of cancer forms mediated by histone deacetylase. Proposed composition and combination comprises the effective amount of benzamide derivatives of the formula (5): 
and other anticancer active substance chosen from group consisting of cisplatin, etoposide, camptothecin, 5-fluorouracil, gemcitabine, paclitaxel, docetaxel, carboplatin, oxaplatin, doxorubicin and vinblastine. Invention provides high effectiveness of treatment and decreasing toxicity.
EFFECT: valuable medicinal properties of pharmaceutical composition, enhanced effectiveness of treatment.
106 cl, 13 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR USING HISTONE DEACETYLASE AND BIOMARKER MONITORING IN COMBINED THERAPY | 2007 |
|
RU2446796C2 |
| METHOD FOR MAKING AND PRESCRIBING SPHAELACTONE DERIVATE AND ITS COMPOSITES | 2011 |
|
RU2537319C2 |
| ANTICANCER COMPOSITION | 2019 |
|
RU2789245C2 |
| COMBINED CHEMOTHERAPY | 2006 |
|
RU2429838C2 |
| COMBINED CHEMOTHERAPY | 2010 |
|
RU2587013C2 |
| METHODS AND COMPOSITIONS FOR TREATING CANCER | 2009 |
|
RU2508116C2 |
| METHODS OF TREATING CANCER USING APILIMOD | 2016 |
|
RU2738934C2 |
| METHODS FOR CANCER TREATMENT USING AUTOPHAGY INHIBITOR BASED ON THIOXANTHONE | 2011 |
|
RU2627588C2 |
| THERAPEUTIC COMBINATIONS CONTAINING RAF INHIBITOR AND ERK INHIBITOR | 2017 |
|
RU2774612C2 |
| DICHLOROACETATES OF SUBSTITUTED N4-[2-(DIMETHYLPHOSPHORYL)PHENYL]-N2-(2-METHOXY-4-PIPERIDIN-1-YLPHENYL)-5-CHLOROPYRIMIDINE-2,4-DIAMINES AS MODULATORS OF ALK AND EGFR, INTENDED FOR TREATING CANCER | 2015 |
|
RU2606951C1 |
